Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,571,191
  • Shares Outstanding, K 29,647
  • Annual Sales, $ 2,312 M
  • Annual Income, $ 1,759 M
  • 60-Month Beta 1.12
  • Price/Sales 6.76
  • Price/Cash Flow 74.05
  • Price/Book 2.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.85
  • Number of Estimates 1
  • High Estimate 1.85
  • Low Estimate 1.85
  • Prior Year 1.61
  • Growth Rate Est. (year over year) +14.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
457.03 +14.92%
on 07/07/20
540.06 -2.75%
on 07/30/20
+59.76 (+12.84%)
since 07/06/20
3-Month
425.43 +23.46%
on 06/25/20
540.06 -2.75%
on 07/30/20
+75.23 (+16.72%)
since 05/06/20
52-Week
309.38 +69.77%
on 03/23/20
540.06 -2.75%
on 07/30/20
+204.41 (+63.72%)
since 08/06/19

Most Recent Stories

More News
The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court's Award of Damages

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced that the United States Court of Appeals for the Federal Circuit today...

BIO : 525.22 (-0.39%)
Bio-Rad Labs-A Set to Possibly Rebound After Yesterday's Selloff of 3.15%

Bio-Rad Labs-A (NYSE:BIO) traded in a range yesterday that spanned from a low of $496.14 to a high of $528.90. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $521.30...

BIO : 525.22 (-0.39%)
Bio-Rad (BIO) Q2 Earnings Beat Estimates, Gross Margin Rises

Bio-Rad's (BIO) second-quarter 2020 results reflect strong performance by the Life Sciences segment, boosted by coronavirus-led increased testing demand.

PKI : 119.05 (-2.49%)
TMO : 415.73 (-0.99%)
WST : 273.89 (-0.28%)
BIO : 525.22 (-0.39%)
Bio-Rad: 2Q Earnings Snapshot

HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO.B) on Thursday reported second-quarter net income of $966.4 million.

BIO : 525.22 (-0.39%)
Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Surpass Estimates

Bio-Rad (BIO) delivered earnings and revenue surprises of 23.85% and 1.91%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

BIO : 525.22 (-0.39%)
Bio-Rad: 2Q Earnings Snapshot

HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO) on Thursday reported second-quarter profit of $966.4 million.

BIO : 525.22 (-0.39%)
Bio-Rad Reports Second-Quarter 2020 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30, 2020....

BIO : 525.22 (-0.39%)
Medical Products Stock Earnings on Jul 30: BAX, SYK & More

Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.

SYK : 188.59 (+0.34%)
BAX : 80.37 (-0.11%)
TFX : 369.57 (-1.25%)
QDEL : 285.35 (-5.50%)
BIO : 525.22 (-0.39%)
Bio-Rad (BIO) to Report Q2 Earnings: What's in the Offing?

Strength in product demand related to COVID-19 testing and research is likely to have aided Bio-Rad's (BIO) performance in second-quarter 2020 amid the coronavirus-led economic doldrums.

IART : 47.81 (-0.08%)
LH : 189.77 (-1.94%)
BIO : 525.22 (-0.39%)
EXAS : 90.40 (-1.68%)
5 Healthcare Stocks to REJUVENATE Your Portfolio

Abbot Laboratories (ABT), Penumbra (PEN), Align (ALGN), Bio-Rad (BIO), and ABIOMED (ABMD) are all steaming higher as doctor's and dentist's offices reopen. There is pent-up demand for these companies'...

ABT : 101.75 (-0.38%)
PEN : 232.75 (-1.41%)
ALGN : 301.80 (+1.10%)
ABMD : 314.98 (-0.64%)
BIO : 525.22 (-0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BIO with:

Business Summary

Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials,...

See More

Key Turning Points

2nd Resistance Point 533.65
1st Resistance Point 529.43
Last Price 525.22
1st Support Level 520.76
2nd Support Level 516.31

See More

52-Week High 540.06
Last Price 525.22
Fibonacci 61.8% 451.94
Fibonacci 50% 424.72
Fibonacci 38.2% 397.50
52-Week Low 309.38

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar